The Potential for CYP2D6 Inhibition Screening Using a Novel Scintillation Proximity Assay-Based Approach

This publication has 16 references indexed in Scilit:

• Description of a 96-Well Plate Assay to Measure Cytochrome P4503A Inhibition in Human Liver Microsomes Using a Selective Fluorescent Probe
  Analytical Biochemistry, 1999
• Inhibitory monoclonal antibodies to human cytochrome P450 enzymes: a new avenue for drug discovery
  Trends in Pharmacological Sciences, 1999
• Advances in in vitro drug metabolism screening
  Pharmaceutical Science & Technology Today, 1999
• Fully automated analysis of activities catalysed by the major human liver cytochrome P450 (CYP) enzymes: assessment of human CYP inhibition potential
  Xenobiotica, 1999
• What lessons can be learnt from withdrawal of mibefradil from the market?
  The Lancet, 1998
• Application of a generic fast gradient liquid chromatography tandem mass spectrometry method for the analysis of cytochrome P450 probe substrates
  Rapid Communications in Mass Spectrometry, 1998
• Preclinical Drug Metabolism in the Age of High-Throughput Screening: An Industrial Perspective
  Pharmaceutical Research, 1997
• Role of Cytochrome P450 Enzymes in Drug-Drug Interactions
  1997
• Measurement of Liver Microsomal Cytochrome P450 (CYP2D6) Activity Using [O-methyl-14C] Dextromethorphan
  Analytical Biochemistry, 1994
• Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
  Biochemical Pharmacology, 1973